Your browser doesn't support javascript.
loading
AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling.
Karwi, Qutuba G; Bornbaum, Julia; Boengler, Kerstin; Torregrossa, Roberta; Whiteman, Matthew; Wood, Mark E; Schulz, Rainer; Baxter, Gary F.
Afiliação
  • Karwi QG; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
  • Bornbaum J; College of Medicine, University of Diyala, Diyala, Iraq.
  • Boengler K; Institute of Physiology, Justus-Liebig-University, Giessen, Germany.
  • Torregrossa R; Institute of Physiology, Justus-Liebig-University, Giessen, Germany.
  • Whiteman M; Medical School, University of Exeter, Exeter, UK.
  • Wood ME; School of Biosciences, University of Exeter, Exeter, UK.
  • Schulz R; Medical School, University of Exeter, Exeter, UK.
  • Baxter GF; School of Biosciences, University of Exeter, Exeter, UK.
Br J Pharmacol ; 174(4): 287-301, 2017 02.
Article em En | MEDLINE | ID: mdl-27930802
BACKGROUND AND PURPOSE: H2 S protects myocardium against ischaemia/reperfusion injury. This protection may involve the cytosolic reperfusion injury salvage kinase (RISK) pathway, but direct effects on mitochondrial function are possible. Here, we investigated the potential cardioprotective effect of a mitochondria-specific H2 S donor, AP39, at reperfusion against ischaemia/reperfusion injury. EXPERIMENTAL APPROACH: Anaesthetized rats underwent myocardial ischaemia (30 min)/reperfusion (120 min) with randomization to receive interventions before reperfusion: vehicle, AP39 (0.01, 0.1, 1 µmol·kg-1 ), or control compounds AP219 and ADT-OH (1 µmol·kg-1 ). LY294002, L-NAME or ODQ were used to investigate the involvement of the RISK pathway. Myocardial samples harvested 5 min after reperfusion were analysed for RISK protein phosphorylation and isolated cardiac mitochondria were used to examine the direct mitochondrial effects of AP39. KEY RESULTS: AP39, dose-dependently, reduced infarct size. Inhibition of either PI3K/Akt, eNOS or sGC did not affect this effect of AP39. Western blot analysis confirmed that AP39 did not induce phosphorylation of Akt, eNOS, GSK-3ß or ERK1/2. In isolated subsarcolemmal and interfibrillar mitochondria, AP39 significantly attenuated mitochondrial ROS generation without affecting respiratory complexes I or II. Furthermore, AP39 inhibited mitochondrial permeability transition pore (PTP) opening and co-incubation of mitochondria with AP39 and cyclosporine A induced an additive inhibitory effect on the PTP. CONCLUSION AND IMPLICATIONS: AP39 protects against reperfusion injury independently of the cytosolic RISK pathway. This cardioprotective effect could be mediated by inhibiting PTP via a cyclophilin D-independent mechanism. Thus, selective delivery of H2 S to mitochondria may be therapeutically applicable for employing the cardioprotective utility of H2 S.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organofosforados / Proteínas Quinases / Tionas / Traumatismo por Reperfusão Miocárdica / Transdução de Sinais / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organofosforados / Proteínas Quinases / Tionas / Traumatismo por Reperfusão Miocárdica / Transdução de Sinais / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2017 Tipo de documento: Article